TrialNature medicine2024
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial.
Othman Al-Sawaf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it
TrialNature medicine2024
Othman Al-Sawaf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.